Quick Takeaways
- BlackRock, Inc. filed SCHEDULE 13G for Kura Oncology, Inc. Common Stock (KURA).
- Disclosed ownership: 10%.
- Date of event: 31 Dec 2024.
BlackRock, Inc. - 31 Dec 2024 SCHEDULE 13G Report for Kura Oncology, Inc. Common Stock (KURA)
- Filing Manager
- BlackRock, Inc.
- Reporting Manager
- BlackRock, Inc.
- Security
- Kura Oncology, Inc. Common Stock
- Symbol
- KURA
- Shares outstanding
- 77,785,333 shares
- Disclosed Ownership
- 7,934,104 shares
- Ownership
- 10%
- Form type
- SCHEDULE 13G
- Filing time
- 08 Jan 2025, 19:42:48 UTC
- Date of event
- 31 Dec 2024
- Next filing
- 17 Apr 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"BlackRock, Inc. disclosed 10% ownership in Kura Oncology, Inc. Common Stock (KURA) on 31 Dec 2024."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 08 Jan 2025, 19:42.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (1)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| BlackRock, Inc. | 10% | 7,934,104 | 7,698,622 | 0 | Spencer Fleming | Managing Director |